title: Clarify the negatives of the MIRASOL noninferiority trial.
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Strauss
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000517:prevention & control*; D001792:Blood Platelets / Q000187:drug effects / Q000528:radiation effects; D001793:Blood Preservation / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D019337:Hematologic Neoplasms / Q000150:complications; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D017713:Platelet Transfusion / Q000009:adverse effects / Q000379:methods*; D012256:Riboflavin / Q000009:adverse effects / Q000494:pharmacology*; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome; D014466:Ultraviolet Rays; D055815:Young Adult
chemical_list: D012256:Riboflavin